Patents Assigned to Evive Biotechnology (Shanghai) Ltd
  • Use of IL-22 dimer in manufacture of a medicament for intravenous administration
    Patent number: 11654104
    Abstract: The present application provides methods of administering an IL-22 dimer to an individual, such as a human individual, comprising intravenously administering to the individual an effective amount of an IL-22 dimer, wherein the amount of the IL-22 dimer is about 2 ?g/kg to about 200 ?g/kg (such as about 10 ?g/kg to about 45 ?g/kg), as well as methods of treating diseases by following such administration methods. Also provided are kits, unit dosages, and articles of manufacture for use in any one of the methods described herein.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: May 23, 2023
    Assignee: Evive Biotechnology (Shanghai) Ltd
    Inventors: Xiaoqiang Yan, Cheng Huang, Dongdong Wu, Kaiyang Tang, Yuliang Huang
  • Use of IL-22 in treating necrotizing enterocolitis
    Patent number: 11510966
    Abstract: The present invention relates to methods of preventing and/or treating necrotizing enterocolitis or other intestinal inflammations using an IL-22, a dimer or a multimer thereof.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: November 29, 2022
    Assignees: Evive Biotechnology (Shanghai) Ltd, University Of Pittsburgh—Of The Commonwealth System Of Higher Education
    Inventors: Jay Kennedy Kolls, Misty Lynn Good, Xiaoqiang Yan